コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ine, thiazole, quinoxaline, benzoxazole, and quinolone.
2 which makes this enzyme produce the diketide quinolone.
3 ) to form the signal molecule 2-heptyl-4(1H)-quinolone.
4 pare patients treated with azithromycin vs a quinolone.
5 a promoter for the synthesis of substituted quinolones.
6 elective metalation of various chromones and quinolones.
7 s internal standards to quantify the (fluoro)quinolones.
8 milar enantioselectivities as the respective quinolones.
9 ute to protection of E. coli DNA gyrase from quinolones.
10 i as well as of man-made antibiotics such as quinolones.
11 to pyridyl 4,5-dihydro-[1,2,4]triazolo[4,3-a]quinolones.
12 ins (four cases), cephalosporins (41 cases), quinolones (15 cases), and pristinamycin (seven cases) w
13 ent publications report in vitro activity of quinolone 3-esters against the bc1 protein complex of Pl
17 of antibiotic resistance were in classes of quinolones (42.0%), sulfonamides (24.0%), tetracyclines
18 nd in-house screening of a limited number of quinolones (50 compounds) identified approximately 100 h
19 d out to downselect the most promising 4(1H)-quinolones, 7, 62, 66, and 67, which possessed low-nanom
22 was associated with use of: later generation quinolones, (adjusted odds ratio [aOR]: 2.5 [95% CI 1.1-
23 olin: adjusted OR = 0.49; 95% CI, 0.34-0.71; quinolone: adjusted OR = 0.55; 95% CI, 0.35-0.87) for co
30 f orally efficacious antimalarials including quinolone analogue 20g, a promising candidate for furthe
31 es conducted in parallel revealed that 4(1H)-quinolone analogues are limited by poor solubilities and
32 activity relationship (SAR) studies on 4(1H)-quinolone analogues identified several key features for
33 r the anthranilate-derived production of the quinolone and acridone alkaloid by type III polyketide s
34 thaliana and that the plant is sensitive to quinolone and aminocoumarin antibiotics, compounds that
36 o resistance to sub-lethal concentrations of quinolone and beta-lactam antibiotics primarily through
37 ions is a two-point hydrogen bonding between quinolone and catalyst enabling efficient energy transfe
39 ruginosa PAO1-based 2-heptyl-3-hydroxy-4(1H)-quinolone and N-(3-oxododecanoyl)-l-homoserine lactone r
40 ing (QS) molecules, 2-heptyl-3-hydroxy-4(1H)-quinolone and N-(3-oxododecanoyl)-l-homoserine lactone,
41 d to compare the rate of perforation between quinolone and neomycin plus hydrocortisone ear drop-expo
42 occus aureus genes involved in resistance to quinolones and beta-lactams, such as those encoding the
43 vel class of N-linked aminopiperidinyl alkyl quinolones and naphthyridones that kills Mtb by inhibiti
44 racis topoisomerase IV, their sensitivity to quinolones and related drugs and their use of metal ions
45 l molecules including Pseudomonas-associated quinolones and rhamnolipids in feces, setting the stage
46 t-off values of beta-lactams, tetracyclines, quinolones and sulfonamides were determined to be 8 ng/m
49 for interactions between clinically relevant quinolones and topoisomerase IV and provide a likely mec
50 ng/mL for tetracyclines, 0.08-2.0 ng/mL for quinolones, and 0.1-3.98 ng/mL for sulfonamides, with li
51 id not bind GyrA fragments bound by CcdB and quinolones, and a set of strains resistant to a variety
53 -level susceptibility to most macrolides and quinolones, and moderate susceptibility to most tetracyc
54 iously postulated antineoplastic activity of quinolones, and suggest that ciprofloxacin might be a si
56 and microbiological evaluation of chromone-, quinolone-, and benzoxazinone-3-sulfonamide derivatives
63 ingly, among these candidate inhibitors were quinolone antibiotics and HIV integrase inhibitors, whic
65 raphic method for the determination of seven quinolone antibiotics in tissue of Atlantic salmon (Salm
66 s the capacity of magnetite to bind not only quinolone antibiotics such as nalidixic acid (NA) and fl
70 nes were shown to sensitize P. aeruginosa to quinolones, antibiotics that elicit a strong SOS respons
71 o failure/relapse or death: later generation quinolones, (aOR: 2.7 [1.7-4.3]), ofloxacin (aOR: 2.3 [1
76 n led to the selection of 2-bisaryl 3-methyl quinolones as a series for further biological evaluation
80 llographic and biochemical studies show that quinolone binding involves a water/metal-ion bridge betw
82 he data support the existence of a secondary quinolone-binding mode in which the quinolone C7 ring sy
83 ificities and produces not only acridone and quinolone but also chalcone, benzophenone, and phloroglu
84 nvolves a water/metal-ion bridge between the quinolone C3-C4 keto-acid and amino acids in helix-4 of
85 econdary quinolone-binding mode in which the quinolone C7 ring system interacts with GyrA; the data a
86 ether the infected strains were resistant to quinolone can be performed simultaneously on a single ch
88 completely restored by treatment with benzyl quinolone carboxylic acid (BQCA) and benzoquinazoline-12
90 ated the actions at an M(1) DREADD of benzyl quinolone carboxylic acid (BQCA), a positive allosteric
91 ently described allosteric modulator, benzyl quinolone carboxylic acid (BQCA), behaves according to a
93 sclosures of an independent discovery of the quinolone class of antibacterials have been almost entir
95 cepts point to new approaches for developing quinolone-class compounds that have increased potency ag
96 up other than the commonly used pyridine and quinolone classes for Cp*Co(III) -catalyzed C(sp(3) )-H
98 norA transcription and reduced resistance to quinolone compared to the wild-type strain, indicating t
100 fly examined leading to the selection of the quinolone core as the key target for structure-activity
102 itution pattern on the benzenoid ring of the quinolone core significantly influenced reactivity with
103 f heterocycles, within the side chain of the quinolone core, was carried out, and this approach led t
105 give ring-fused indoles B, quinolines C, or quinolones D depending on the reaction conditions employ
107 The 6-amino-7-[4-(2-pyridinyl)-1-piperazinyl]quinolone derivative 8 proved to be the best compound of
108 ty of vosaroxin, a first-in-class anticancer quinolone derivative, plus cytarabine in patients with r
112 nt SIMS imaging at the same location detects quinolone distributions in excellent agreement with the
114 that an A. thaliana mutant resistant to the quinolone drug ciprofloxacin has a point mutation in ATG
115 argeted DNA gyrase that is the target of the quinolone drug ciprofloxacin; this has important consequ
121 ification, resulting in metabolically stable quinolones effective against multi drug resistant (MDR)
126 cs, beta-lactam (ampicillin and penicillin), quinolone (enoxacin), aminoglycoside (kanamycin and neom
127 g modes raises the possibility that multiple quinolone-enzyme-DNA complexes can form, a discovery tha
128 preliminary structural optimization of 4(1H)-quinolone ester derivatives, a new series of antimalaria
130 ructure-activity relationship study on 4(1H)-quinolones, focusing on the reduction of cross-resistanc
131 A synthesis inhibitors (fluoroquinolones and quinolones), folic acid synthesis inhibitors (sulfonamid
133 tween the lowest energy hydroxyquinoline and quinolone forms is 27 and 38 kJ mol(-1), for 5Me-HQE and
134 ence for the preparation of functionalized 4-quinolones from 2-iodoanilines and alkynes via two diffe
136 tivity of some aryl propionic acids, (fluoro)quinolones, furocoumarins, metal coordination complexes,
139 isolates were found to be susceptible to the quinolone group of antibiotics (moxifloxacin followed by
142 ely used to treat bacterial infections, some quinolones have unexplained side effects, including deat
143 ne known inhibitor, hydroxy-2-dodecyl-4-(1H)-quinolone (HDQ), and this was used along with a range of
144 cifically, our data indicate that 2-heptyl-4-quinolone (HHQ), a precursor of PQS, likely induces the
146 rther demonstrated in synthesis of quinoline-quinolone hybrid as well as 6-aryl-benzofuro[3,2-c]quino
152 nfection among isolates usually sensitive to quinolones in the levofloxacin group vs placebo (14/24 [
153 rylacrylamides are cyclized to substituted 2-quinolones in the presence of CuI, PPh(3), and KO-t-Bu i
154 +) concentration required to produce maximal quinolone-induced DNA cleavage and restricted the divale
158 hila AhQnr, is soluble, stable, and relieves quinolone inhibition of Escherichia coli DNA gyrase, thu
159 s are proposed to serve as a critical enzyme-quinolone interaction site by anchoring a water-metal io
160 water-metal ion bridge that is critical for quinolone interactions with other bacterial type II topo
164 quinolone signal (PQS; 2-heptyl-3-hydroxy-4-quinolone) is one of these signals, and it is known to b
165 sing resistance to multiple drugs, including quinolones, is associated with decreased susceptibility
168 quent Mtb screening of the complete in-house quinolone library (350 compounds) identified a further a
169 Homogenized fresh whole egg spiked with nine quinolones (marbofloxacin, norfloxacin, ciprofloxacin, d
170 ity, and suggest that re-engineering certain quinolones might help develop newer antibacterials.
171 and it controls the production of 2-alkyl-4-quinolone molecules which are important for pathogenicit
173 for isoniazid, 98.7% for rifampin, 97.6% for quinolones (ofloxacin, levofloxacin, or moxifloxacin), 9
174 cin, sarafloxacin and difloxacin), and three quinolones (oxolinic acid, nalidixic acid and flumequine
176 m beta-lactamase-producing type SHV-12), and quinolones (plasmid-mediated quinolone resistance gene q
178 QS signal molecule 2-heptyl-3-hydroxy-4(1H)-quinolone (PQS), a minimal medium containing PQS as the
179 n which the cytotoxicity of beta-lactams and quinolones predominantly results from lethal double-stra
182 The small molecule 2-heptyl-3-hydroxy-4-quinolone (Pseudomonas Quinolone Signal [PQS]) is one of
184 ient preparation of 2-heptyl-3-hydroxy-4(1H)-quinolone (Pseudomonas quinolone signal or PQS) and a di
186 quality control material for the analysis of quinolone residues in egg samples has been prepared.
188 he topoisomerase genes, but plasmid-mediated quinolone resistance (PMQR) mechanisms have also been de
189 gyrB, parC, and parE and/or plasmid-mediated quinolone resistance (PMQR) mechanisms including qnr var
190 d for Escherichia coli with plasmid-mediated quinolone resistance (PMQR), extended-spectrum beta-lact
191 industrial region in India were analyzed for quinolone resistance (qnr) genes by quantitative PCR.
194 t mutations at GyrA(A90) and GyrA(D94) cause quinolone resistance by disrupting the bridge-enzyme int
198 Comprehensive data on the prevalence of quinolone resistance in Mycobacterium tuberculosis clini
199 y 0, 1 carried E. coli with a lower level of quinolone resistance on day 0, and 4 carried E. coli wit
201 evalence of resistance mutations outside the quinolone resistance-determining region (QRDR) of gyrA o
206 lmonella due to chromosomal mutations in the quinolone resistance-determining regions (QRDRs) of the
211 gyrB, Rv2686c, Rv2687c, and Rv2688c genes in quinolone-resistant and year-of-diagnosis-matched M. tub
213 bacteriostatic activity for Cip-AcCl with a quinolone-resistant GyrA-G81C variant of Escherichia col
214 nt antibacterial activity, including against quinolone-resistant isolates, but suffer from hERG inhib
215 nother multivariate analysis performed among quinolone-resistant isolates, treatment failure was 3 ti
216 e fecal microbiota, no proof of selection of quinolone-resistant mutants from the initial microbiota
220 Acinetobacter baumannii [8], carbapenem- and quinolone-resistant Pseudomonas aeruginosa [26], and der
222 s with varying substituents on the benzenoid quinolone ring and/or the 3-position were synthesized an
224 he general 6-chloro-7-methoxy-2-methyl-4(1H)-quinolone scaffold which were substituted at the 3-posit
225 ive antimalarial pharmacophores, such as the quinolone scaffold, to yield potent and highly efficacio
226 een appended to the C7 position of different quinolone scaffolds do not take advantage of specific co
227 e envisioned, and then created, novel 4-(1H)-quinolone scaffolds that target the cytochrome bc1 compl
228 Moreover we show that, as in bacteria, the quinolone-sensitive (wild-type) allele is dominant to th
229 Extensive physicochemical evaluation of the quinolone series was carried out to downselect the most
230 improve the overall efficacy, multiple 4(1H)-quinolone series with varying substituents on the benzen
231 by P. aeruginosa and whether the Pseudomonas quinolone signal (PQS) and the MucD periplasmic protease
232 tyl-4-hydroxyquinoline (HHQ) and Pseudomonas quinolone signal (PQS) are involved in the regulation of
238 ing, particularly in the rhl and Pseudomonas quinolone signal (PQS) systems, was significantly muted
239 nteracting with the iron-binding Pseudomonas quinolone signal (PQS), a cell-cell signalling compound.
240 so promote the production of the Pseudomonas quinolone signal (PQS), a quorum sensing molecule that a
241 modulation of the levels of the Pseudomonas quinolone signal (PQS), a quorum signal previously shown
246 2-heptyl-3-hydroxy-4-quinolone (Pseudomonas Quinolone Signal [PQS]) is one of these signals and its
248 h as the quorum-sensing molecule Pseudomonas quinolone signal and the exopolysaccharide Psl, is regul
249 eptyl-3-hydroxy-4(1H)-quinolone (Pseudomonas quinolone signal or PQS) and a diverse range of structur
251 qsR acts as the receptor for the Pseudomonas quinolone signal, and it controls the production of 2-al
252 cteristic fatty acids (e.g., palmitic acid), quinolone signal, and riboflavin fragments were found to
253 ed that phz1 is regulated by the Pseudomonas quinolone signal, factors controlling phz2 expression ha
255 ins, carbohydrates, and, for the first time, quinolone signaling molecules-in Pseudomonas-derived bio
257 nt agreement with the CRM, discerns multiple quinolone species which differ slightly in mass, resolve
258 from the kynurenine pathway or from an alkyl quinolone specific anthranilate synthase encoded by phnA
261 nd, shifting from 4-quinolone to 4-hydroxy-2-quinolone structure enabled the discovery of a novel cla
265 genetically characterized, and compared with quinolone-susceptible E. coli (QSEC) strains collected o
268 Two novel type III polyketide synthases, quinolone synthase (QNS) and acridone synthase (ACS), we
269 ion of a novel Type III polyketide synthase, quinolone synthase (QNS), from A. marmelos that is invol
270 identification of a characteristic FabH-like quinolone synthase from Pseudomonas aeruginosa with high
272 like the unrelated F-encoded toxin CcdB and quinolones, targeted the GyrA subunit and stalled the DN
273 tic elements and resistance determinants for quinolones, tetracyclines, and beta-lactamases are share
274 g-binding mode in which the other end of the quinolone, the C7 ring system, interacts with GyrA.
275 the critically important antimicrobials were quinolones, third- and fourth-generation cephalosporins,
277 raoxonase 2 (PON2) inhibitor (Triazolo[4,3-a]quinolone, TQ416) significantly affected recovering cell
280 60-member library of tricyclic 2,3-dihydro-4-quinolones using a combination of solution-phase high-th
281 ivity by diversification of an azide-bearing quinolone via a sequence of [4 + 2] cycloadditions, N-ac
282 95% confidence interval [CI], 5.0%-8.2%) for quinolones vs 6.4% (95% CI, 5.0%-7.9%) for azithromycin
284 dium berghei in mice showed that these 4(1H)-quinolones were efficacious for the reduction of parasit
292 dary metabolites, including rhamnolipids and quinolones, were detected and visualized on both macro-
293 of QnrB1 on DNA gyrase toward inhibition by quinolones, whereas deletion of the smaller lower loop d
294 inhibition of the catalytic process by other quinolones, which could potentially compete with the bin
295 The biological evaluation illustrated that 4-quinolones with a benzylamide function in position 3 and
296 in, we report the lead optimization of 4(1H)-quinolones with a focus on improving both antimalarial p
298 ly diverse 6-chloro-2-methyl-7-methoxy-4(1H)-quinolones with EC(50) in the low nanomolar range agains
299 lected aptamers were shown to detect various quinolones with high specificity, while specific binding
300 rent in vitro assay identified several 4(1H)-quinolones with nanomolar EC(50) against erythrocytic st
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。